ORBIMED ADVISORS LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is a Director in Anthera Pharmaceuticals Inc ($ANTH) and a Director in Volcano Corp ($VOLC) and a 10% Owner in COMPLETE GENOMICS INC ($GNOM) and a 10% Owner in Pacira Pharmaceuticals, Inc. ($PCRX).
Address: 767 THIRD AVENUE, 30TH FLOOR NEW YORK 10017 NY
Companies in which ORBIMED ADVISORS LLC is an Insider
Anthera Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 2,831,800 shares
Current Value: $1,670,762
Latest Transaction: Dec 13 2011
$ANTH Market Capitalization: $23.84M
$ANTH Previous Close: $0.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
COMPLETE GENOMICS INC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 39,211 shares
Latest Transaction: Nov 16 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Pacira BioSciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 2,731,500 shares
Current Value: $114,040,125
Latest Transaction: Nov 02 2011
$PCRX Market Capitalization: $1.57B
$PCRX Previous Close: $41.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Volcano Corp
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 195,705 shares
Latest Transaction: Jun 20 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC
Sentiment: All, ANTH, GNOM, PCRX, VOLC
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 02 2011 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 10.53 | 887 | 9,336 | 2,731,500 | 2.7 M to 2.7 M (-0.03 %) |
| Nov 02 2011 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 10.53 | 96,554 | 1,016,298 | 2,732,387 | 2.8 M to 2.7 M (-3.41 %) |
| Dec 13 2011 | ANTH | Anthera Pharmaceut ... | ORBIMED ADVISORS LLC | Director | Sell | S | 6.50 | 16,200 | 105,300 | 2,831,800 | 2.8 M to 2.8 M (-0.57 %) |
| Dec 13 2011 | ANTH | Anthera Pharmaceut ... | ORBIMED ADVISORS LLC | Director | Sell | S | 6.75 | 40,000 | 270,000 | 2,848,000 | 2.9 M to 2.8 M (-1.39 %) |
| Nov 18 2011 | ANTH | Anthera Pharmaceut ... | ORBIMED ADVISORS LLC | Director | Sell | S | 6.50 | 3,000 | 19,500 | 2,888,000 | 2.9 M to 2.9 M (-0.10 %) |
| Nov 18 2011 | ANTH | Anthera Pharmaceut ... | ORBIMED ADVISORS LLC | Director | Sell | S | 6.67 | 24,000 | 160,080 | 2,891,000 | 2.9 M to 2.9 M (-0.82 %) |
| Nov 18 2011 | ANTH | Anthera Pharmaceut ... | ORBIMED ADVISORS LLC | Director | Sell | S | 6.87 | 25,000 | 171,750 | 2,915,000 | 2.9 M to 2.9 M (-0.85 %) |